Percutaneous Endoscopic Sigmoidopexy Shows Promise for Recurrent Sigmoid Volvulus
A new systematic review highlights the effectiveness and safety of percutaneous endoscopic sigmoidopexy in patients with recurrent sigmoid volvulus, offering a less invasive alternative to traditional surgery.
Recurrent sigmoid volvulus—a twisting of the sigmoid colon that can cause severe abdominal pain and bowel obstruction—has long challenged surgeons. Traditional treatment often involves open or laparoscopic surgery, which carries higher risks and longer recovery times. A recent systematic review published in Cureus now points to a minimally invasive endoscopic approach that could change the game.
What’s New?
The review, titled “Percutaneous Endoscopic Sigmoidopexy for Recurrent Sigmoid Volvulus: A Systematic Review of Efficacy, Safety, and Clinical Outcomes,” collates data from multiple studies to evaluate how well the procedure works and how safe it is for patients.
Key Findings
- Efficacy: The procedure consistently prevented recurrence in the majority of patients across the studies.
- Safety: Complication rates were low, with most adverse events being mild and manageable.
- Clinical Outcomes: Patients experienced shorter hospital stays and quicker return to normal activities compared to conventional surgery.
Why It Matters
Sigmoid volvulus can be life‑threatening if not treated promptly. Recurrent cases increase the risk of complications and repeat hospitalizations. The endoscopic technique offers:
- A less invasive option that reduces surgical trauma.
- Lower hospital costs due to shorter stays.
- Faster recovery times, allowing patients to resume daily activities sooner.
Expert Take
While the systematic review provides encouraging evidence, experts note that the procedure requires specialized training and equipment. Surgeons should weigh the benefits against the learning curve and patient selection criteria.
Future Outlook
Ongoing research aims to refine patient selection, optimize procedural techniques, and gather long‑term outcome data. If future studies confirm these early results, percutaneous endoscopic sigmoidopexy could become the preferred first‑line treatment for recurrent sigmoid volvulus.
For patients and clinicians, this review underscores the importance of staying informed about emerging minimally invasive options that can improve outcomes and reduce healthcare burdens.
Discover more from NewzQuest
Subscribe to get the latest posts sent to your email.
